Ipca Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IPCA LABS, and what generic and branded alternatives to IPCA LABS drugs are available?
IPCA LABS has thirty approved drugs.
Drugs and US Patents for Ipca Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ipca Labs Ltd | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 206387-003 | Jun 4, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Ipca Labs Ltd | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 205983-005 | May 20, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Ipca Labs Ltd | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 078955-004 | Jun 2, 2008 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.